OUTSET MEDICAL INC (OM)

US6901451079 - Common Stock

1.27  -0.13 (-9.29%)

After market: 1.3 +0.03 (+2.36%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
102.6M
105.61%
115.4M
12.48%
130.376M
12.98%
115.44M
-11.46%
129.02M
11.76%
140.65M
9.01%
162.59M
15.60%
196.63M
20.94%
222.38M
13.10%
252.66M
13.62%
EBITDA
YoY % growth
-125.34M
-9.72%
-155.83M
-24.33%
-163.96M
-5.22%
-76.941M
53.07%
-51.363M
33.24%
-43.878M
14.57%
-35.329M
19.48%
-5.356M
84.84%
8.858M
265.38%
26.368M
197.67%
EBIT
YoY % growth
-130.5M
-11.16%
-161M
-23.37%
-169.77M
-5.45%
-82.469M
51.42%
-54.35M
34.10%
-41.166M
24.26%
-37.853M
8.05%
-8.034M
78.78%
5.768M
171.79%
22.763M
294.64%
Operating Margin
-127.19%-139.51%-130.22%-71.44%-42.12%-29.27%-23.28%-4.09%2.59%9.01%
EPS
YoY % growth
-2.88
50.12%
-3.41
-18.40%
-3.10
9.09%
-1.91
38.53%
-1.38
27.84%
-1.16
15.36%
-1.01
12.83%
-0.42
58.38%
-0.13
68.29%
0.23
269.23%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth
-0.42
29.59%
-0.36
36.75%
-0.35
25.05%
-0.33
14.96%
-0.33
20.66%
-0.42
-17.14%
-0.39
-11.11%
-0.35
-5.59%
-0.32
3.12%
Revenue
Q2Q % growth
28.749M
-5.76%
30.552M
8.46%
31.394M
14.63%
32.841M
14.56%
34.233M
19.08%
47.689M
56.09%
51.397M
63.72%
54.796M
66.85%
60.255M
76.01%
EBITDA
Q2Q % growth
-16.034M
49.17%
-14.317M
59.62%
-13.287M
52.26%
-11.845M
39.31%
-11.879M
25.91%
-19.055M
-33.09%
-17.407M
-31.01%
-15.553M
-31.30%
-13.596M
-14.45%
EBIT
Q2Q % growth
-17.33M
53.61%
-15.45M
58.14%
-14.42M
53.13%
-12.944M
45.70%
-12.909M
25.51%
-20.497M
-32.67%
-18.952M
-31.43%
-17.098M
-32.10%
-15.141M
-17.29%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth
-0.39
45.07%
-0.430.0410.20%
Q2 2024
Q2Q % growth
-0.47
47.78%
-0.470.00-1.03%
Q1 2024
Q2Q % growth
-0.57
36.67%
-0.570.00-0.88%
Q4 2023
Q2Q % growth
-0.59
31.40%
-0.630.046.86%
Q3 2023
Q2Q % growth
-0.71
16.47%
-0.69-0.02-3.40%
Q2 2023
Q2Q % growth
-0.90
2.17%
-0.79-0.11-14.59%
Q1 2023
Q2Q % growth
-0.90
-15.38%
-0.76-0.14-17.76%
Q4 2022
Q2Q % growth
-0.86
1.15%
-0.890.032.91%
Q3 2022
Q2Q % growth
-0.85
-30.77%
-0.83-0.02-1.88%
Q2 2022
Q2Q % growth
-0.92
-39.39%
-0.72-0.20-27.97%
Q1 2022
Q2Q % growth
-0.78
-11.43%
-0.74-0.04-5.18%
Q4 2021
Q2Q % growth
-0.87
-16.00%
-0.79-0.08-10.05%
Q3 2021
Q2Q % growth
-0.65
80.36%
-0.750.1013.55%
Q2 2021
Q2Q % growth
-0.66 -0.720.068.20%
Q1 2021
Q2Q % growth
-0.70 -0.840.1416.25%
Q4 2020
Q2Q % growth
-0.75 -0.68-0.07-9.66%
Q3 2020
Q2Q % growth
-3.31 -3.20-0.11-3.55%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth
28.666M
-5.59%
27.712M954K3.44%
Q2 2024
Q2Q % growth
27.388M
-24.01%
32.123M-4.735M-14.74%
Q1 2024
Q2Q % growth
28.168M
-15.83%
31.251M-3.083M-9.87%
Q4 2023
Q2Q % growth
30.507M
-4.70%
31.316M-809K-2.58%
Q3 2023
Q2Q % growth
30.362M
9.37%
31.302M-940K-3.00%
Q2 2023
Q2Q % growth
36.04M
43.81%
35.838M202K0.56%
Q1 2023
Q2Q % growth
33.467M
9.55%
32.712M755K2.31%
Q4 2022
Q2Q % growth
32.01M
13.71%
31.85M160K0.50%
Q3 2022
Q2Q % growth
27.76M
5.47%
25.979M1.781M6.86%
Q2 2022
Q2Q % growth
25.06M
-0.63%
28.316M-3.256M-11.50%
Q1 2022
Q2Q % growth
30.55M
33.29%
31.013M-463K-1.49%
Q4 2021
Q2Q % growth
28.15M
63.19%
27.218M932K3.42%
Q3 2021
Q2Q % growth
26.32M
91.28%
25.876M444K1.72%
Q2 2021
Q2Q % growth
25.22M
114.82%
24.448M772K3.16%
Q1 2021
Q2Q % growth
22.92M
218.78%
22.096M824K3.73%
Q4 2020
Q2Q % growth
17.25M 14.167M3.083M21.76%
Q3 2020
Q2Q % growth
13.76M 11.908M1.852M15.55%
Q2 2020
Q2Q % growth
11.74M
309.06%
%
Q1 2020
Q2Q % growth
7.19M
188.76%
%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% -39.88% 0% -0.18%
Revenue0% -40.77% -0.04% 1.68%